- Maple Leaf Green World (MGW) has signed a non-binding letter of intent with Biolinear Technologies
- The companies will use Biolinear’s nanotechnology to design, produce, and sell cannabinoid-based products with enhanced drug delivery capabilities
- Maple Leaf plans on conducting further due diligence in the coming weeks and will continue negotiations as the joint venture is finalized
- Maple Leaf is a public Canadian company that is focused on the hemp industry in North America
- Maple Leaf Green World Inc. (MGW) is currently down 7.14 per cent, trading at $0.13 per share
Maple Leaf Green World (MGW) has signed a non-binding letter of intent with Biolinear Technologies to design cannabinoid-based products.
Biolinear has developed technologies including the Cannabinoid Enhancement System (CES), GelPatch™, and NanoSpheres™.
“I believe these technologies are the future of the industry and having the opportunity to utilize them in our products is expected to provide a significant competitive advantage,” said Raymond Lai, Maple Leaf’s president and CEO.
In a joint venture, the companies will use Biolinear’s nanotechnology to design, produce, and sell cannabinoid-based products with enhanced drug delivery capabilities.
Biolinear’s CES is a patented technology that dissolves isolates, crudes, or distillates into a pure Molecular Solution that unlocks the full potential of cannabinoid products.
“We have developed industry leading technology at Biolinear and are excited to get them in the hands of consumers through this JV,” said Biolinear president Alan Stier. “We anticipate that our technology, paired with the production capabilities of Maple Leaf, will enable us to be a formidable player in the cannabinoid market.”
Maple Leaf Green World plans on conducting further due diligence in the coming weeks and will continue negotiations as the joint venture is finalized. The company recognizes this partnership as an opportunity to advance the commercialization of products that utilize Biolinear’s technologies.
Maple Leaf is a public Canadian company that is focused on the hemp industry in North America.
The company’s long-term objective is to produce cannabis oil and to export its products to approved countries and currently owns a hemp project in Southern California.
Maple Leaf Green World Inc. (MGW) is currently down 7.14 per cent, trading at $0.13 per share as of 2:28 pm ET.